A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints

@article{Dalhoff2009ALJ,
  title={A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving Breakpoints},
  author={A. Dalhoff and P. Ambrose and J. Mouton},
  journal={Infection},
  year={2009},
  volume={37},
  pages={296-305}
}
  • A. Dalhoff, P. Ambrose, J. Mouton
  • Published 2009
  • Medicine, Biology
  • Infection
  • AbstractSince the origin of an "‘International Collaborative Study on Antibiotic Sensitivity Testing’" in 1971, considerable advancement has been made to standardize clinical susceptibility testing procedures of antimicrobial agents. However, a consensus on the methods to be used and interpretive criteria was not reached, so the results of susceptibility testing were discrepant. Recently, the European Committee on Antimicrobial Susceptibility Testing achieved a harmonization of existing methods… CONTINUE READING
    63 Citations

    Figures, Tables, and Topics from this paper.

    Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
    • 13
    New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
    • T. Gumbo
    • Medicine
    • Antimicrobial Agents and Chemotherapy
    • 2010
    • 115
    • PDF
    Declining susceptibilities of gram-negative bacteria to the fluoroquinolones: effects on pharmacokinetics, pharmacodynamics, and clinical outcomes.
    • M. Labreche, C. Frei
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2012
    • 21

    References

    SHOWING 1-10 OF 62 REFERENCES
    Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests.
    • 182
    • PDF
    Impact of pharmacodynamics on breakpoint selection for susceptibility testing.
    • J. Mouton
    • Medicine
    • Infectious disease clinics of North America
    • 2003
    • 51
    Antimicrobial Susceptibility Breakpoints
    • P. Ambrose
    • Medicine
    • Treatments in respiratory medicine
    • 2005
    • 14
    Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.
    • 95
    Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.
    • D. Andes, W. Craig
    • Medicine
    • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
    • 2005
    • 109
    • Highly Influential
    History and development of antimicrobial susceptibility testing methodology.
    • P. F. Wheat
    • Medicine, Biology
    • The Journal of antimicrobial chemotherapy
    • 2001
    • 65
    • PDF
    Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis.
    • 44
    • PDF